| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial
|
Lindsay, James O
|
|
2017
|
2 |
6 |
p. 399-406
8 p.
|
artikel
|
| 2 |
Beyond the Milan criteria for liver transplantation in children with hepatic tumours
|
de Ville de Goyet, Jean
|
|
2017
|
2 |
6 |
p. 456-462
7 p.
|
artikel
|
| 3 |
Broken but hopeful
|
Dorn, Aaron van
|
|
2017
|
2 |
6 |
p. 397-398
2 p.
|
artikel
|
| 4 |
Correction to Lancet Gastroenterol Hepatol 2017; 2: 427–34
|
|
|
2017
|
2 |
6 |
p. e3-
1 p.
|
artikel
|
| 5 |
Early age at diagnosis of hepatocellular carcinoma in sub-Saharan Africa
|
Shimakawa, Yusuke
|
|
2017
|
2 |
6 |
p. 393-
1 p.
|
artikel
|
| 6 |
Early age at diagnosis of hepatocellular carcinoma in sub-Saharan Africa – Authors' reply
|
Yang, Ju Dong
|
|
2017
|
2 |
6 |
p. 394-
1 p.
|
artikel
|
| 7 |
Lessons in post-infectious IBS: the Walkerton tragedy
|
Mohammadi, Dara
|
|
2017
|
2 |
6 |
p. 396-
1 p.
|
artikel
|
| 8 |
Long-term challenges and perspectives of pre-adolescent liver disease
|
Hadžić, Nedim
|
|
2017
|
2 |
6 |
p. 435-445
11 p.
|
artikel
|
| 9 |
More than what meets the mouth and nose
|
Lau, Esther
|
|
2017
|
2 |
6 |
p. 397-
1 p.
|
artikel
|
| 10 |
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study
|
Petta, Salvatore
|
|
2017
|
2 |
6 |
p. 427-434
8 p.
|
artikel
|
| 11 |
Paediatric liver disease: lessons for adult practice
|
Kelly, Deirdre A
|
|
2017
|
2 |
6 |
p. 390-392
3 p.
|
artikel
|
| 12 |
PARP inhibitors and chemoradiation for rectal cancer
|
Glynne-Jones, Rob
|
|
2017
|
2 |
6 |
p. 389-390
2 p.
|
artikel
|
| 13 |
Research in brief
|
Baker, Holly
|
|
2017
|
2 |
6 |
p. 395-
1 p.
|
artikel
|
| 14 |
Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study
|
Czito, Brian G
|
|
2017
|
2 |
6 |
p. 418-426
9 p.
|
artikel
|
| 15 |
Stem-cell transplantation for Crohn's disease: same authors, different conclusions?
|
Burt, Richard K
|
|
2017
|
2 |
6 |
p. 386-387
2 p.
|
artikel
|
| 16 |
S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial
|
Kudo, Masatoshi
|
|
2017
|
2 |
6 |
p. 407-417
11 p.
|
artikel
|
| 17 |
The intestinal microbiome and paediatric liver disease
|
Leung, Daniel H
|
|
2017
|
2 |
6 |
p. 446-455
10 p.
|
artikel
|
| 18 |
The opioid crisis: the needle and the damage done
|
The Lancet Gastroenterology & Hepatology,
|
|
2017
|
2 |
6 |
p. 385-
1 p.
|
artikel
|
| 19 |
The role (if any) of chemotherapy in hepatocellular carcinoma
|
El Dika, Imane
|
|
2017
|
2 |
6 |
p. 387-389
3 p.
|
artikel
|
| 20 |
When gluten attacks
|
Sargent, Jennifer
|
|
2017
|
2 |
6 |
p. 398-
1 p.
|
artikel
|
Tijdschrift beschrijving